BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30569573)

  • 41. ERK3 and DGKζ interact to modulate cell motility in lung cancer cells.
    Myers AK; Morel M; Gee SH; Hoffmann KA; Long W
    Front Cell Dev Biol; 2023; 11():1192221. PubMed ID: 37287450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
    Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The atypical MAPK ERK3 controls positive selection of thymocytes.
    Sirois J; Daudelin JF; Boulet S; Marquis M; Meloche S; Labrecque N
    Immunology; 2015 May; 145(1):161-9. PubMed ID: 25521218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased levels of DUSP6 phosphatase stimulate tumourigenesis in a molecularly distinct melanoma subtype.
    Li W; Song L; Ritchie AM; Melton DW
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):188-99. PubMed ID: 22171919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted inactivation of Mapk4 in mice reveals specific nonredundant functions of Erk3/Erk4 subfamily mitogen-activated protein kinases.
    Rousseau J; Klinger S; Rachalski A; Turgeon B; Déléris P; Vigneault E; Poirier-Héon JF; Davoli MA; Mechawar N; El Mestikawy S; Cermakian N; Meloche S
    Mol Cell Biol; 2010 Dec; 30(24):5752-63. PubMed ID: 20956558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
    Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
    Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression.
    Julien C; Coulombe P; Meloche S
    J Biol Chem; 2003 Oct; 278(43):42615-24. PubMed ID: 12915405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3.
    Hansen CA; Bartek J; Jensen S
    Cell Cycle; 2008 Feb; 7(3):325-34. PubMed ID: 18235225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma.
    Kunz M; Ibrahim S; Koczan D; Thiesen HJ; Köhler HJ; Acker T; Plate KH; Ludwig S; Rapp UR; Bröcker EB; van Muijen GN; Flory E; Gross G
    Cell Growth Differ; 2001 Mar; 12(3):137-45. PubMed ID: 11306514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation.
    El-Merahbi R; Viera JT; Valdes AL; Kolczynska K; Reuter S; Löffler MC; Erk M; Ade CP; Karwen T; Mayer AE; Eilers M; Sumara G
    Genes Dev; 2020 Apr; 34(7-8):495-510. PubMed ID: 32139423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
    Huang GX; Wang Y; Su J; Zhou P; Li B; Yin LJ; Lu J
    Cancer Lett; 2017 Dec; 410():1-11. PubMed ID: 28923399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
    Gao L; Feng Y; Bowers R; Becker-Hapak M; Gardner J; Council L; Linette G; Zhao H; Cornelius LA
    Cancer Res; 2006 Aug; 66(16):7880-8. PubMed ID: 16912161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
    Chen ZH; Wang LH
    Am J Dermatopathol; 2019 Dec; 41(12):908-913. PubMed ID: 31021836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.
    Schönherr M; Bhattacharya A; Kottek T; Szymczak S; Köberle M; Wickenhauser C; Siebolts U; Saalbach A; Koczan D; Magin TM; Simon JC; Kunz M
    Pigment Cell Melanoma Res; 2014 May; 27(3):418-30. PubMed ID: 24406113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
    Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
    BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of extracellular signal-regulated kinase 3 as a new interaction partner of cyclin D3.
    Sun M; Wei Y; Yao L; Xie J; Chen X; Wang H; Jiang J; Gu J
    Biochem Biophys Res Commun; 2006 Feb; 340(1):209-14. PubMed ID: 16360641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
    Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
    Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
    Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
    Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth.
    Hao H; Muniz-Medina VM; Mehta H; Thomas NE; Khazak V; Der CJ; Shields JM
    Mol Cancer Ther; 2007 Aug; 6(8):2220-9. PubMed ID: 17699719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.